trial · primary record
GSK5926371
Lymphoma, Non-Hodgkin
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 49 |
| Primary completion | 2030-01-10 |
| Primary endpoint | Number of participants with dose limiting toxicities (DLTs) |
| Registry ID | NCT07607925 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:43:28.247Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07607925
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.